News & Insights

August Equity is pleased to announce the agreement to realise its investment in Hallmarq Veterinary Imaging (“Hallmarq”) through a sale to funds advised by NORD Holding to support the strategic combination of Hallmarq and OR Technology. 

Hallmarq is the global leader in advanced imaging systems to the veterinary sector. Since August invested in Hallmarq it has grown to serve customers in over 28 countries and has doubled its revenue. During the investment, Hallmarq won a Queen’s Award for Innovation recognising the development of the 1.5T high-field MRI scanner designed for small animals.  

The August investment team was led by David Lonsdale, John Western and Michael Coates and represents another successful exit from August Equity Partners IV.  

Commenting on the divestment David Lonsdale Managing Partner said “Hallmarq has been through a period of extensive growth and international expansion. We are delighted to realise another successful exit from Fund IV and our wider animal health franchise. It has been great to work with the Hallmarq team and we wish them well in this next chapter with NORD Holding.” 

August was advised by Arrowpoint Advisory (Corporate Finance), Travers Smith (Legal), CIL (Commercial), RSM (Financial) and EY (Tax).